International Journal of Clinical Research

Objective To evaluate the clinical efficacy of Nimodipine in treating migraines. Methods A total of 120 migraine patients treated at our hospital between January 2023 and June 2024 were enrolled. Patients were randomly assigned into two control groups using a digital randomization system. The control group received conventional medications, while the observation group received Nimodipine therapy. Results The observation group demonstrated statistically significant symptom relief (P <0.05) across all indicators. The total number of effective patients in the observation group reached 29 (96.67%), showing a higher efficacy rate with statistically significant differences (P <0.05). Conclusion Nimodipine demonstrates remarkable effectiveness in migraine treatment, providing significant symptom relief with high safety profile. This medication warrants clinical promotion and widespread application.

Nimodipine; Migraine; Clinical treatment; Therapeutic effect; Pain level